跳至主要内容
临床试验/DRKS00005636
DRKS00005636已完成不适用

on-interventional study investigating Actikerall® II in patients with actinic keratosis (clinical grade I or II according to Olsen) on hands and/or underarms

Almirall Hermal GmbH0 个研究点目标入组 649 人开始时间: 2014年1月14日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
649

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Enrolled patients are to be patients suffering from actinic keratosis (clinical stage I or II according to Olsen) on hands and/or underarms, who are to be treated with Actikerall® based upon physicians´ therapeutic decision.

排除标准

  • hypersensitivity to fluorouracil/ salicylic acid or any other component of Actikerall®
  • planned or existing pregnancy or nursing period
  • renal insufficiency
  • (pre-)medication containing brivudine, sorivudine or analogs, that has been terminated less than four weeks prior to therapy start with Actikerall®
  • Immune suppression

研究者

相似试验